Brief: Cns Pharmaceuticals Files Prospectus For Secondary Offering Of Up To 3.8 Million Shares Of Common Stock
Nov 20 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS FILES PROSPECTUS FOR SECONDARY
OFFERING OF
UP TO 3.8 MILLION SHARES OF COMMON STOCK - SEC FILING
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026